Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seung Up Kim

Showing results (11-20 of 524) with videos related to

Pageof 53
Sort By:
Clinical and Molecular Hepatology|September 24, 2024
Correspondence to editorial on "Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis"Jung Hwan Yu, Seung Up Kim
Clinical and Molecular Hepatology|October 7, 2024
Correspondence to editorial on "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis"Young-Joo Jin, Seung Up Kim
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' replyHan Ah Lee, Seung Up Kim
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' replyHan Ah Lee, Seung Up Kim
European Journal of Gastroenterology & Hepatology|October 6, 2011
Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascitesSun Min Lim, Seung Up Kim
Clinical and Molecular Hepatology|May 8, 2025
Correspondence to letter to the editor on "Risk Stratification of Metabolic Dysfunction-Associated Steatotic Liver Disease: The KASL PathwayHye Won Lee, Seung Up Kim
Clinical and Molecular Hepatology|June 24, 2025
Correspondence to letter to the editor on "Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease"Hye Won Lee, Seung Up Kim
Gut and Liver|January 8, 2025
Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver DiseaseJong Ryeol Eun, Seung Up Kim
Hepatology International|November 23, 2019
Sarcopenia: an emerging risk factor for non-alcoholic fatty liver diseaseYong-Ho Lee, Seung Up Kim
Journal of Hepatology|September 17, 2015
Reply to "Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue"Beom Kyung Kim, Seung Up Kim
Pageof 53

Showing results (11-20 of 524) with videos related to

Sort By:
Pageof 53
Clinical and Molecular Hepatology|September 24, 2024
Correspondence to editorial on "Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis"Jung Hwan Yu, Seung Up Kim
Clinical and Molecular Hepatology|October 7, 2024
Correspondence to editorial on "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis"Young-Joo Jin, Seung Up Kim
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' replyHan Ah Lee, Seung Up Kim
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' replyHan Ah Lee, Seung Up Kim
European Journal of Gastroenterology & Hepatology|October 6, 2011
Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascitesSun Min Lim, Seung Up Kim
Clinical and Molecular Hepatology|May 8, 2025
Correspondence to letter to the editor on "Risk Stratification of Metabolic Dysfunction-Associated Steatotic Liver Disease: The KASL PathwayHye Won Lee, Seung Up Kim
Clinical and Molecular Hepatology|June 24, 2025
Correspondence to letter to the editor on "Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease"Hye Won Lee, Seung Up Kim
Gut and Liver|January 8, 2025
Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver DiseaseJong Ryeol Eun, Seung Up Kim
Hepatology International|November 23, 2019
Sarcopenia: an emerging risk factor for non-alcoholic fatty liver diseaseYong-Ho Lee, Seung Up Kim
Journal of Hepatology|September 17, 2015
Reply to "Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue"Beom Kyung Kim, Seung Up Kim
Pageof 53